Novel anti-CD19 plus lenalidomide prolonged survival in R/R DLBCL ExpertDr Grzegorz Nowakowski, Mayo Clinic, Rochester, USA TrialCohort study, RE-MIND2 ConferenceASH 2021 TypeNews article 4 February 2022 11:08